Oncothyreon to Present at 2012 Wedbush Pacgrow Lifesciences Management Access Conference
SEATTLE, WA, Aug. 8, 2012 /PRNewswire/ - Oncothyreon Inc. (Nasdaq: ONTY) announced today that management will present at the 2012 Wedbush Pacgrow Lifesciences Management Access Conference in New York on Wednesday, August 15, 2012 at 8:35 a.m. Eastern.
A live and archived webcast of the presentation will be accessible by visiting the Oncothyreon website www.oncothyreon.com under the "News & Events" section.
Oncothyreon is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Oncothyreon's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients. For more information, visit www.oncothyreon.com.
SOURCE Oncothyreon Inc.
More by this Source
Oncothyreon Reports Third Quarter 2013 Financial Results
Nov 12, 2013, 16:00 ET
Oncothyreon Announces Presentation of Data from Phase 1Trial of ONT-10
Nov 08, 2013, 08:00 ET
Oncothyreon Announces Third Quarter 2013 Financial Results Conference Call
Nov 04, 2013, 08:00 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.